1月3日,陆道培医疗集团向港交所主板提交上市申请,中信证券、招银国际及麦格理为其联席保荐人。据弗若斯特沙利文的资料,截至2021年,以收入、血液病床位数量及造血干细胞移植仓位计,陆道培医疗集团是全国最大的血液病医疗服务机构。而以造血干细胞移植病例计,该机构排名国内第二,同时公司也是国内血液病特检服务第三大服务供应商。资料显示,陆道培医疗集团的创始人,正是我国骨髓移植事业奠基人、中国工程院院士陆道培...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.